Wealthspire Advisors (Maryland)’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
TCM
Wealthspire Advisors (Maryland)'s ANGO Position: Q2 2019 in Review
Wealthspire Advisors (Maryland) sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 72 shares — an estimated $2K sold.
Wealthspire Advisors (Maryland) first reported a position in ANGO in Q3 2017 and held it in 4 quarters. The position peaked at $2K in Q1 2019. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.
- Wealthspire Advisors (Maryland) reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
- Wealthspire Advisors (Maryland) sold 72 AngioDynamics shares in Q2 2019, an estimated $2K.
- Wealthspire Advisors (Maryland) first reported a position in AngioDynamics in Q3 2017 and held it in 4 quarters.
- Wealthspire Advisors (Maryland)'s AngioDynamics position peaked at $2K in Q1 2019.
- 167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.
Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.